Costa Del Sol Healthcare
COSTA DEL SOL HEALTHCARE in LOS ANGELES, CA — inspection on November 17, 2025.
Found 2 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
During a review of the facility's P&P titled Blood Glucose Monitoring and Quality Control, dated 10/2025, the P&P indicated quality control testing for both high and low ranges should be completed daily and documented on the quality control log.
During a review of the facility's Job Description: LVN, dated 2/2024, the Job description indicated LVNs were responsible for ensuring all equipment is maintained at all times to meet the needs of the residents and ensure to chart routinely in accordance with documentation policies.
Facility ID:
IDENTIFICATION NUMBER:
A.
Building
COMPLETED
11/17/2025
STREET ADDRESS, CITY, STATE, ZIP CODE
Costa Del Sol Healthcare
1016 S.
Record St.
Los Angeles, CA 90023
SUMMARY STATEMENT OF DEFICIENCIES
Summary Report, dated [DATE], the Order Summary Report indicated an order of Insulin Glargine (long-acting insulin for DM) dated [DATE].During a concurrent observation and interview on [DATE] at 8:05 a.m. with Licensed Vocational Nurse (LVN 1), Resident 1 had an opened Insulin Glargine pen that was not labelled with date opened or expiration date. LVN 1 stated the LVN who opened the insulin pen should have labelled the insulin pen with date opened and expiration date.During a concurrent interview and record review with Pharmacist 1 (Pharm 1), the Insulin Glargine Full Prescribing Information, dated 6/2022, was reviewed.
Pharm 1 stated the Instructions for use indicated Insulin Glargine pens should not be administered 28 days after storing at room temperature, opening, or first use of the pen.
Pharm 1 stated Insulin Glargine pens must be labeled with the open date and expiration date.
During an interview on [DATE] at 12:01 p.m. with LVN 3, LVN 3 stated all insulin pens must be labeled with the open and expiration dates so licensed nurses know when it was opened and when the expiration date would be and will not have the risk of administering an expired insulin to Resident 1.
During an interview on [DATE] at 2:45 p.m. with LVN 1, LVN 1 stated she would not know when Resident 1's Insulin Glargine pen was opened because the insulin was not labelled with date. LVN 1 stated it placed Resident 1 at risk of receiving expired insulin medication because the insulin pen was not labelled.During a concurrent interview and record review on [DATE] at 3:00 p.m. with the Director of Nursing (DON), the facility's P&P titled Medication Labeling and Storage, dated 2/2023, was reviewed.
The DON stated the P&P indicated multi-dose vials that have been opened or accessed must be dated and discarded within 28 days.
The DON stated the P&P was not followed when the licensed nurse did not label Resident 1's Insulin Glargine pen with the date when opened and the expiration date.During a review of the facility's P&P titled Medication Labeling and Storage, dated 2/2023, the P&P indicated the medication label should include the expiration date.
The P&P indicated multi-dose vials that have been opened or accessed must be dated and discarded within 28 days unless the manufacturer specifies a shorter or longer date for the open vial.During a review of the Insulin Glargine Full Prescribing Information, dated 6/2022, the Insulin Glargine Full Prescribing Information indicated room temperature or in-use single-resident-used prefilled pens can only be stored for 28 days.
Facility ID: